Corrigendum to “Intranasal Administration of the Growth-Compromised HSV-2 Vector ΔRR Prevents Kainate-Induced Seizures and Neuronal Loss in Rats and Mice”
Molecular Therapy - United States
doi 10.1038/sj.mt.6300211
Full Text
Open PDFAbstract
Available in full text
Date
September 1, 2007
Authors
Publisher
Elsevier BV